HARVARD BIOSCIENCE, INC. Contract Liability (Deferred Revenue)
HARVARD BIOSCIENCE, INC. (HBIO) had Contract Liability (Deferred Revenue) of $3.60 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-11
- 2026-06-30: Contract with Customer, Liability, Current $3.60M.
- 2026-03-31: Contract with Customer, Liability, Current $3.67M.
- 2025-12-31: Contract with Customer, Liability, Current $3.45M.
- 2025-09-30: Contract with Customer, Liability, Current $2.88M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $3.60M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $3.67M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $3.45M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $2.88M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $3.14M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $3.43M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $3.81M 10-K · filed 2026-03-13 |
| 2024-09-30 | $3.69M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $4.01M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $4.39M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $4.51M 10-K · filed 2025-03-14 |
| 2023-09-30 | $4.00M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $3.83M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $4.12M 10-Q · filed 2023-04-26 |
| 2022-12-31 | $3.37M 10-K · filed 2024-03-07 |
| 2022-09-30 | $3.64M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $3.61M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.96M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $4.27M 10-K · filed 2023-03-09 |
| 2021-09-30 | $3.62M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $3.67M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $3.64M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $3.77M 10-K · filed 2022-03-11 |
| 2020-09-30 | $3.56M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $3.65M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $3.67M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $3.95M 10-K/A · filed 2021-03-17 |
| 2018-12-31 | $3.82M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |